FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE; NOTICE OF MEETING; ESTABLISHMENT OF A PUBLIC DOCKET; REQUEST FOR COMMENTS-SAFETY AND EFFECTIVENESS OF MFLUSIVA (INFLUENZA VACCINE, MRNA) MANUFACTURED BY MODERNA TX INC.

WASHINGTON, May 22 -- Food and Drug Administration has issued a notice called: Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) Manufactured by Moderna TX Inc.

The notice was published in the Federal Register on May 22 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA on regulator...